Publications by authors named "John D Shepherd"

Claim this Profile
O
Outcomes of Telerehabilitation Versus In-Office Training With Magnification Devices for Low Vision: A Randomized Controlled Trial.
Ava K Bittner, John E Kaminski, Patrick D Yoshinaga, John D Shepherd, Tiffany L Chan

Transl Vis Sci Technol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of Handheld Optical Illuminated Magnifiers for Sustained Silent Reading by Visually Impaired Adults.
John E Kaminski, Patrick D Yoshinaga, Melissa W Chun, Megan Yu, John D Shepherd

Optom Vis Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vision Rehabilitation Preferred Practice Pattern®.
Mary Lou Jackson, Gianni Virgili, John D Shepherd, Marie A Di Nome, Donald Calvin Fletcher

Ophthalmology· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telerehabilitation Training to Facilitate Improved Reading Ability with New Magnification Devices for Low Vision.
Ava Katherine Bittner, John E Kaminski, Nicole C Ross, John D Shepherd, Stacy J Thoene

Optom Vis Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptability of Telerehabilitation for Magnification Devices for the Visually Impaired Using Various Approaches to Facilitate Accessibility.
Ava K Bittner, Patrick D Yoshinaga, John D Shepherd, John E Kaminski, Alexis G Malkin

Transl Vis Sci Technol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Vision Services and the Glaucoma Patient.
Mona A Kaleem, Bonnielin K Swenor, Sheila K West, Lily Im, John D Shepherd

Ophthalmol Glaucoma· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Telerehabilitation for Low Vision: Satisfaction Ratings by Providers and Patients.
Ava Katherine Bittner, Patrick Yoshinaga, Angie Bowers, John D Shepherd, Tony Succar

Optom Vis Sci· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vision Rehabilitation Preferred Practice Pattern®.
Joseph L Fontenot, Mark D Bona, Mona A Kaleem, William M McLaughlin, Alan R Morse, John D Shepherd

Ophthalmology· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma.
Alden A Moccia, Felicitas Hitz, Paul Hoskins, Richard Klasa, Maryse M Power, John D Shepherd

Leuk Lymphoma· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation.
Haowei Sun, Kerry J Savage, Aly Karsan, Graham W Slack, Randy D Gascoyne, John D Shepherd

Clin Lymphoma Myeloma Leuk· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal karyotype CALLA-positive adult pre-B ALL: dismal outcome with chemotherapy for patients with loss/gain of ABL1 and/or BCR FISH signals.
Yasser R Abou Mourad, Rahul Bhargava, Hélène Bruyère, Tanya Gillian, Michael J Barnett, John D Shepherd

Clin Lymphoma Myeloma Leuk· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SCI-U: e-learning for patient education in spinal cord injury rehabilitation.
John D Shepherd, Karla M Badger-Brown, Matthew S Legassic, Saagar Walia, Dalton L Wolfe

J Spinal Cord Med· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy.
Adisak Tantiworawit, Maryse M Power, Michael J Barnett, Donna E Hogge, Stephen H Nantel, John D Shepherd

Leuk Lymphoma· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.
Cynthia L Toze, Chinmay B Dalal, Thomas J Nevill, Tanya L Gillan, Yasser R Abou Mourad, John D Shepherd

Br J Haematol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months).
Christopher P Venner, Joseph M Connors, Heather J Sutherland, John D Shepherd, Linda Hamata

Leuk Lymphoma· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation.
Matthew P Wright, John D Shepherd, Michael J Barnett, Stephen H Nantel, Heather J Sutherland

Biol Blood Marrow Transplant· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels.
Donna L Forrest, Shannon Trainor, Ryan R Brinkman, Michael J Barnett, Donna E Hogge, John D Shepherd

Leuk Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
Thomas J Nevill, John D Shepherd, Heather J Sutherland, Yasser R Abou Mourad, Julye C Lavoie

Biol Blood Marrow Transplant· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
John Kuruvilla, John D Shepherd, Heather J Sutherland, Thomas J Nevill, Janet Nitta

Biol Blood Marrow Transplant· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors.
Yulia Lin, Hélène Bruyère, Douglas E Horsman, Tapio Pantzar, Michael J Barnett, John D Shepherd

Cancer Genet Cytogenet· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma.
Kevin W Song, Michael J Barnett, Randy D Gascoyne, Douglas E Horsman, Donna L Forrest, John D Shepherd

Br J Haematol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamide.
Asha Johny, Kevin W Song, Stephen H Nantel, Julye C Lavoie, Cynthia L Toze, John D Shepherd

Biol Blood Marrow Transplant· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
Donna L Forrest, Donna E Hogge, Thomas J Nevill, Stephen H Nantel, Michael J Barnett, John D Shepherd

J Clin Oncol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma.
Richard T Doocey, Cynthia L Toze, Joseph M Connors, Thomas J Nevill, Randy D Gascoyne, John D Shepherd

Br J Haematol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of karyotype on outcome of autotransplants for acute myeloid leukemia in second remission.
Kevin W Song, Peter N Mollee, Donna E Hogge, Vikas Gupta, Michael J Barnett, John D Shepherd

Leuk Lymphoma· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis